3-Epiabiraterone-d4 Acetate is labelled 3-Epiabiraterone Acetate (E577000), a stereoisomer of Abiraterone acetate (A108500) which is a novel steroidal inhibitor of human Cytochrome P450 (17α-Hydroxylase-C17,20-lyase): potential agent for the treatment of prostatic cancer.